In Palestinian pediatric clinics, two recurring fever conditions — one rooted in inherited genetics, the other in periodic immune disruption — are proving difficult to tell apart. A study of 169 children found that nearly one in five who appeared to have familial Mediterranean fever also met the clinical definition of PFAPA syndrome, a finding that does not confirm the two diseases coexist but does reveal how porous the boundary between them can be. Medicine's categories, it seems, do not always hold still when pressed against the complexity of a child's body.
Study reveals clinical overlap between FMF and PFAPA in Palestinian children
Clinical overlap but not proof of two diseases
Mark
So nearly one in five kids with FMF symptoms also looked like they had PFAPA. That's a lot of overlap. Does that mean they actually have both diseases?
Mimi
That's the question the researchers won't answer, and that's actually the honest part. They found clinical overlap—kids whose symptoms fit both classification systems. But they can't say whether that means two diseases in one child or whether the classifications themselves are just catching the same underlying thing from different angles.
Luke
Right, and there's a data problem underneath. Ninety percent of the FMF-only kids got genetic testing, but only fifty-nine percent of the PFAPA-overlap kids did. That's a huge gap. You can't really compare groups when one has way more genetic information than the other.
Mimi
Exactly. And it's retrospective—they're looking back at medical records that weren't created for research purposes. Different doctors may have documented the same symptom differently, or missed things entirely.
Mark
What about the genetics? M694V showed up in most of them. Does that tell us anything?
Mimi
M694V is the most common FMF variant overall, and it's associated with more severe disease. But among the kids who had both FMF and PFAPA features, the pattern was different—more of them were heterozygous carriers, meaning they had only one copy of the mutation, and E148Q was more common in that group.
Luke
But again, only nineteen of the thirty-two PFAPA-overlap kids had genetic testing. You're drawing conclusions about a pattern from less than two-thirds of the group. The other thirteen—you don't know what they carried.
Mark
So what should a doctor actually do with this?
Mimi
It tells them that in Palestinian populations especially, the symptoms of FMF and PFAPA can genuinely look alike, and you might see kids who fit both descriptions. That's useful clinically—it means don't assume you know which one it is just from the fever pattern and the sore throat.
Luke
And it tells them that the classification systems themselves might need refinement for this population. But it doesn't tell them that these kids have two diseases. It tells them the classifications overlap, which is different.
El Pulso
- Clinicians at two Palestinian medical centers are confronting a diagnostic fog: children presenting with recurring fevers, abdominal pain, mouth sores, and swollen lymph nodes that refuse to belong neatly to one disease.
- Nearly one-fifth of children flagged for familial Mediterranean fever simultaneously met the clinical criteria for PFAPA syndrome, a rate high enough to unsettle standard classification frameworks.
- Genetic testing revealed that the severe M694V variant dominated FMF cases, while children in the overlapping group more often carried only a single mutated gene copy — a distinction with uncertain clinical meaning.
- Unequal access to genetic testing skewed the data: over ninety percent of FMF-only children had genetic confirmation, compared to fewer than sixty percent of those with overlapping features.
- Researchers are urging restraint — the study shows symptomatic overlap, not proven disease coexistence, and retrospective record review cannot substitute for prospective, uniformly collected evidence.
In Palestinian pediatric clinics, two recurring fever conditions — one rooted in inherited genetics, the other in periodic immune disruption — are proving difficult to tell apart. A study of 169 children found that nearly one in five who appeared to have familial Mediterranean fever also met the clinical definition of PFAPA syndrome, a finding that does not confirm the two diseases coexist but does reveal how porous the boundary between them can be. Medicine's categories, it seems, do not always hold still when pressed against the complexity of a child's body.
Two childhood fever conditions that look strikingly alike are generating a diagnostic puzzle in Palestinian pediatric medicine. Researchers examining 169 children with symptoms consistent with familial Mediterranean fever — a genetic inflammatory disorder causing recurring fever, abdominal pain, and joint swelling — found that thirty-two of them, nearly one in five, also satisfied the clinical criteria for PFAPA syndrome, a separate condition marked by periodic fever, mouth sores, sore throat, and swollen lymph nodes. The overlap is significant enough to complicate how doctors classify and treat these children, though the study stops well short of claiming both diseases are present simultaneously.
Drawing on records from two Palestinian medical centers, the team used established international classification systems to retrospectively sort clinical and genetic data. Among 143 children who underwent MEFV gene testing, the M694V variant — associated with more severe disease — appeared in nearly sixty percent of cases. Among children with overlapping PFAPA-compatible features who had genetic data available, the milder E148Q variant in a single gene copy was most common. Crucially, genetic testing was far more complete for FMF-only patients than for those in the overlapping group, a disparity that limits what conclusions can fairly be drawn.
The authors are deliberate in their restraint. Shared symptoms do not prove shared disease, and the retrospective design means clinical documentation may have varied across sites and over time. What the study does establish is that the line between FMF and PFAPA is less distinct than textbooks suggest — particularly in populations where MEFV variants are prevalent. Prospective studies with consistent genetic testing across all patients will be needed before the relationship between these two conditions can be understood with confidence.
Two childhood fevers that look alike are creating a diagnostic puzzle in Palestinian pediatric clinics. Researchers studying 169 children with symptoms consistent with familial Mediterranean fever—a genetic inflammatory condition marked by recurring bouts of fever, abdominal pain, and joint swelling—discovered that nearly one in five of these patients also met the clinical criteria for a different condition called PFAPA syndrome, which presents with periodic fever, mouth sores, sore throat, and swollen neck lymph nodes. The overlap is real enough to complicate how doctors classify and treat these children, yet the study stops short of claiming the two diseases coexist in the same patient.
The research drew from two Palestinian medical centers and examined children eighteen years old and younger who presented with fever patterns fitting familial Mediterranean fever, or FMF. Using established diagnostic frameworks from Eurofever and PRINTO—international classification systems for autoinflammatory diseases—the team retrospectively sorted through clinical records and genetic data. Of the 169 children flagged as having an FMF-compatible presentation, thirty-two also satisfied the clinical definition of PFAPA. That eighteen-point-nine percent overlap signals something clinicians need to reckon with: the symptoms these two conditions produce can blur together, especially in populations where FMF-causing genetic variants run high.
Genetic testing revealed the landscape of mutations driving these fevers. Among 143 children who underwent MEFV gene testing—the gene responsible for FMF—the M694V variant dominated, appearing in fifty-eight-point-seven percent of cases. This variant is known to produce more severe disease. Among the nineteen children with PFAPA-compatible features who had genetic testing, ten carried only a single copy of an MEFV mutation rather than two, making them heterozygous carriers. In this subgroup, the E148Q variant emerged as the most common pattern. The uneven distribution of genetic data matters: ninety point five percent of children classified as FMF-only had genetic confirmation, while only fifty-nine point four percent of those with PFAPA-compatible features did. This gap in testing availability shapes what researchers can actually conclude.
The authors are careful not to overstate their findings. The clinical features that define PFAPA—sore throat, mouth ulcers, swollen lymph nodes—were treated as descriptive observations rather than independent markers separating one group from another. The study demonstrates that children can display symptoms matching both disease classifications, but it does not prove that FMF and PFAPA are two separate conditions occurring simultaneously in the same child, nor does it establish a direct link between specific genetic variants and the overlapping phenotype. The retrospective nature of the work—pulling data from existing medical records rather than following children forward in time—introduces its own constraints. Doctors may have documented symptoms differently across the two centers, or key clinical details may have been missed or recorded inconsistently.
What emerges is a call for caution. The findings point toward genuine clinical overlap in this Palestinian pediatric population, but the unequal access to genetic testing and the limitations of classifying children based on historical medical records mean these results should not be read as definitive proof that the two diseases coexist or that one causes the other. For clinicians working with children who present with recurrent fever, mouth sores, and throat inflammation, the study suggests that the boundary between FMF and PFAPA may be less clear than textbooks imply—at least in populations where MEFV variants are common. Future work with prospective data collection and more uniform genetic testing could sharpen the picture.
Citas Notables
The findings demonstrate clinical overlap but do not establish coexistence of two independent diseases or a causal genotype–phenotype relationship.— Study authors
Quieres la nota completa?
Lee el original en Nature ↗
Health & Medicine